Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-30

Clinical Trial Update: REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ramipril versus nifedipine GITS in reducing blood pressure variability in essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine GITS (nifedipine)
  • Ramipril (ramipril)

Snippet

Sponsor: Istituto Auxologico Italiano | Conditions: Hypertension, High Blood Pressure Variability | Phase 4 | Status: COMPLETED